9:30 Decoding Co-Pathologies to Refine Disease Definitions, Enhance Target Engagement, & Optimize Patient Stratification in Neurodegeneration

  • Navigating overlapping pathologies in AD, PD, ALS, and MS: tau, amyloid, αsynuclein, TDP-43, and others
  • Quantifying and differentiating overlapping pathologies and their impact on diagnosis and treatment
  • What deciphering co-pathologies means for patient stratification and therapeutic targeting